1. Introduction: The pregnancy paradox in interventional radiology

Pregnant patients in interventional radiology present one of the most emotionally charged clinical scenarios in modern medicine. The imperative to deliver life-saving or limb-saving interventions collides with the instinctive fear of harming the developing fetus. Pregnant patients in interventional radiology are not contraindications to care—they are calls for precision, planning, and protocol modification.

Every year, thousands of pregnant women require fluoroscopically guided procedures for conditions ranging from pulmonary embolism and trauma to biliary obstruction and vascular access. The reflex to cancel or delay these procedures often causes more harm than the radiation itself. A delayed embolectomy, deferred biliary drainage, or postponed trauma embolization can escalate maternal morbidity and, by extension, fetal risk. The challenge is not whether to treat, but how to treat with radiation exposure minimized to the lowest achievable level.

The physics are reassuring when protocols are followed. During typical interventional cardiology procedures, fetal exposure ranges from 0.3 μGy to 4.1 μGy per 100 seconds of fluoroscopy time, depending on beam angulation and patient positioning.^[8] Even in worst-case scenarios with prolonged procedures, cumulative fetal doses remain well below thresholds associated with deterministic effects. The key is understanding when risk modification—not cancellation—is the appropriate clinical response.

2. The physics of fetal radiation exposure

Radiation exposure to the fetus during interventional procedures occurs through two primary pathways: scatter from the primary beam and, in rare cases, direct beam transit through the maternal abdomen. For most interventional radiology procedures—especially those targeting the upper body, extremities, or head—the fetus lies outside the primary beam path and receives only scattered radiation.

The intensity of scatter radiation follows the inverse square law and is heavily attenuated by maternal tissues. At 1 meter from the scatter source, an operator absorbs approximately 0.1% of the patient dose.^[20] The fetus, shielded within the uterus and surrounded by amniotic fluid, receives a fraction of that. Phantom studies demonstrate that fetal dose rates during interventional cardiology procedures range from 0.2 μGy to 0.8 μGy per 100 seconds at standard projections, with left breast tissue receiving significantly higher exposure (up to 348 μGy/100s) due to proximity to the heart.^[8]

The gestational age at exposure matters profoundly. In the first 10–14 days post-conception, the all-or-nothing principle applies: doses below approximately 50–100 mGy are unlikely to cause effects other than spontaneous abortion, which occurs naturally in approximately 50% of conceptions.^[2] Between 2 and 15 weeks, the developing central nervous system is most vulnerable, with thresholds for gross malformations and mental retardation beginning around 100–150 mGy. After 15 weeks, the only significant risk is stochastic—principally, radiation-induced cancer—with a lifetime attributable risk of roughly 2% per 50 mGy.^[2]

3. Regulatory dose limits and guidelines

Multiple regulatory bodies have established fetal dose limits for occupational and medical exposure, and these frameworks should guide institutional policy. The International Commission on Radiological Protection (ICRP) recommends that the additional dose to the embryo/fetus of a declared pregnant worker should not exceed approximately 1 mSv during the remainder of the pregnancy.^[10] The U.S. Nuclear Regulatory Commission (NRC) sets a mandatory limit of 5 mSv (0.5 rem) to the embryo/fetus for the entire gestation period.^[11]

The National Council on Radiation Protection and Measurements (NCRP) recommends a more conservative monthly equivalent dose limit of 0.5 mSv once pregnancy is known, with any monthly dose exceeding 1 mSv requiring licensee justification.^[13] These limits are not arbitrary; they reflect the cumulative nature of stochastic risk and the particular radiosensitivity of rapidly dividing fetal tissues.

For medical exposure of pregnant patients—distinct from occupational exposure—dose limits do not apply. Instead, the emphasis falls on justification and optimization. The ACR practice parameter states that for doses under 100 mGy to the conceptus, risks are considered too small to warrant medical intervention.^[2] This threshold provides enormous clinical latitude for most interventional procedures, where fetal doses typically measure in micrograys, not milligrays.

4. Modified protocols for pregnant patients

When a pregnant patient requires an interventional procedure, the protocol should be modified—not the indication discarded. The following modifications represent best practice across SIR, CIRSE, and EAPCI guidelines:^[1][4][20]

• Prefer ultrasound or MRI guidance whenever clinically feasible. Ultrasound-guided vascular access, drainage, and biopsy eliminate ionizing radiation entirely.
• Use pulsed fluoroscopy at the lowest frame rate consistent with procedural safety. Reducing from 15 fps to 7.5 fps or 3 fps can cut patient dose by 50% or more without compromising catheter visibility.
• Collimate aggressively to the smallest field of view that encompasses the anatomy of interest. Every square centimeter of reduced field area directly reduces scatter production.
• Maximize source-to-skin distance and minimize detector-to-patient distance. This geometry reduces entrance skin dose and improves image quality simultaneously.
• Avoid magnification modes unless absolutely necessary. Magnification increases dose rate proportionally to the magnification factor.
• Position the C-arm with the X-ray tube below the patient when possible. This directs scatter toward the floor rather than toward the operator and, by extension, reduces scatter in the room.
• Use last-image-hold for review instead of acquiring additional cine runs. Each second of cine can deliver 10–15 times the dose of one second of fluoroscopy.

For procedures where the primary beam must traverse the gravid uterus—such as pelvic embolization or femoral access with steep angulation—consider fetal dose estimation by a qualified medical physicist. Document the estimated fetal dose in the medical record and communicate it to the obstetric team.^[2]

5. Shielding strategies: Beyond the standard apron

Traditional lead aprons provide excellent attenuation of scattered radiation, but their weight—often 3.5–7.5 kg for 0.5 mm Pb-equivalent garments—creates significant physical burden for pregnant patients and staff alike.^[15] Modern non-lead composite aprons utilizing tungsten, antimony, and bismuth mixtures achieve equivalent or superior attenuation at approximately 20–30% less weight.^[5]

For the pregnant patient on the table, abdominal shielding should be positioned with care. The ACR notes that pelvic shields do not significantly reduce fetal dose when the fetus is outside the primary beam, because scatter from internal Compton interactions dominates the exposure pathway.^[2] However, when the primary beam must traverse the pelvis, a 0.5 mm Pb-equivalent drape placed between the patient and the X-ray tube can attenuate a meaningful fraction of entrance dose.

For pregnant staff, maternity lead aprons with extended front panels and higher lead equivalence (up to 1.0 mm Pb) are recommended.^[14] These garments wrap around the abdomen to shield the fetus from lateral scatter. Additionally, mobile lead barriers of at least 1.0 mm Pb equivalence positioned between the operator and the patient can reduce scatter exposure by 90% or more.^[14]

The SATPro lead-free apron line offers lightweight, high-attenuation solutions specifically engineered for extended wear during long interventional cases. Combined with SATPro scatter-free covers, these products create a multi-layer defense against both primary and scattered radiation.

6. Occupational protection for pregnant staff

Pregnant interventional radiologists, cardiologists, nurses, and technologists can continue to work in the fluoroscopy suite with appropriate precautions. The IAEA explicitly states that pregnant workers may continue performing diagnostic X-rays and interventional procedures provided proper protective measures are used and doses are monitored.^[14]

Key occupational modifications include:

• Wearing two dosimeters: one at the collar outside the lead apron to measure eye dose, and one at the waist under the apron to estimate fetal dose. The under-apron reading multiplied by an appropriate conversion factor provides a conservative fetal dose estimate.
• Adjusting clinical responsibilities to reduce participation in high-dose procedures such as transjugular intrahepatic portosystemic shunt (TIPS) creation, hepatic chemoembolization, and complex peripheral interventions. These procedures routinely generate KAP values exceeding 300 Gy·cm².^[20]
• Stepping behind mobile shields during cine acquisitions. One study demonstrated that stepping back just 60 cm during exposures reduced operator scatter dose by 75% in phantom models.^[20]
• Declaring pregnancy promptly to the radiation safety officer (RSO) so that enhanced monitoring and workplace adjustments can be implemented without delay.

A five-year dosimetry study of anesthesia staff in interventional cardiology found mean annual effective doses ranging from 0.65 mSv to 0.92 mSv—well below occupational limits and demonstrating that careful practice keeps fetal exposure negligible.^[16]

7. Patient communication and informed consent

Informed consent for pregnant patients undergoing interventional radiology must balance transparency with reassurance. The ACR recommends communicating that the lifetime attributable cancer risk from a typical fetal dose of 50 mGy is roughly 2%, but that most interventional procedures deliver doses orders of magnitude lower.^[2] Conversely, there is approximately a 98% likelihood the child will be unaffected by the radiation.

Consent documentation should include:

1. Confirmation that the procedure is medically indicated and that delay or cancellation carries independent risks.
2. A realistic estimate of fetal dose, ideally calculated by a medical physicist for high-risk procedures.
3. Explanation of the specific dose-reduction measures being employed (pulsed fluoro, tight collimation, shielding).
4. Instruction to report any skin changes at the beam entry site within 2–10 weeks for high-dose cases.

Convey information positively rather than catastrophically. Instead of stating “there is a small chance your child could develop cancer,” frame the message as “the likelihood your child will remain healthy with no adverse radiation effects is only slightly different from that of any other child.”^[2]

8. SATMED solutions for pregnancy-safe IR

SATMED Health addresses the global gap in pregnancy-specific radiation protection through integrated hardware, software, and educational infrastructure. The SATPro product ecosystem includes lightweight non-lead aprons that achieve 98.5% scatter attenuation at 0.35 mm Pb-equivalent—critical for pregnant staff who cannot tolerate heavy garments. SATDrape radiation-attenuating sterile drapes fill the void in patient-side peripheral shielding, protecting untargeted anatomy including the gravid uterus during femoral or radial access procedures.

On the software side, SATMED’s cloud EHR integration automatically flags pregnant patients in the scheduling system, prompts protocol modification checklists, and tracks cumulative fetal dose across multiple encounters. When a procedure crosses the 5 Gy skin dose threshold, the system generates mandatory follow-up alerts to obstetrics and dermatology—ensuring no high-dose pregnancy falls through the cracks.

9. Further reading

1. ALARA principles in modern interventional radiology: A 30-day protocol
2. Radiation skin injury follow-up: Post-procedure monitoring essentials
3. Cine versus fluoroscopy: Dose reduction strategies for the IR suite
4. Documenting radiation dose: Medicolegal protection and clinical safety
5. Scatter radiation protection: The step-back reflex for operators

10. Conclusion

Pregnancy is not a contraindication to interventional radiology—it is a mandate for meticulous protocol optimization. By understanding the physics of fetal exposure, adhering to regulatory dose limits, modifying fluoroscopy parameters, and deploying modern lightweight shielding, clinicians can deliver critical care to pregnant patients without compromising fetal safety. The evidence is clear: with proper technique, fetal doses during interventional procedures remain orders of magnitude below thresholds of concern. The greater risk lies in delaying or denying indicated care.

Institutional culture must shift from fear-based cancellation to evidence-based modification. Every interventional suite should maintain pregnancy-specific protocols, stock lightweight composite PPE, and integrate automated dose tracking that flags high-exposure cases for follow-up. These investments protect not only the individual patient and fetus but also the long-term health of the interventional workforce.

11. References

1. Dauer, L. T., Miller, D. L., Schueler, B., Silberzweig, J., Balter, S., Bartal, G., Cardella, J. F., & Society of Interventional Radiology. (2015). Occupational radiation protection of pregnant or potentially pregnant workers in IR: A joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. Journal of Vascular and Interventional Radiology, 26(2), 171–181. https://doi.org/10.1016/j.jvir.2014.11.013
2. American College of Radiology. (2023). ACR–SPR practice parameter for imaging pregnant or potentially pregnant patients with ionizing radiation. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/Pregnant-Pts.pdf
3. Applegate, K. E., Findlay, Ú., Fraser, L., Kinsella, Y., Ainsbury, E. A., & Bouffler, S. D. (2021). Radiation exposures in pregnancy, health effects and risks to the embryo/fetus—information to inform the medical management of the pregnant patient. Journal of Radiological Protection, 41(4), S522–S539. https://doi.org/10.1088/1361-6498/ac2a7b
4. Manzo-Silberman, S., Velazquez, M., Burgess, S., Sahni, S., Best, P., Mehran, R., Windecker, S., & European Association of Percutaneous Cardiovascular Interventions. (2023). Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: A statement of the EAPCI. EuroIntervention, 19(1), 53–62. https://doi.org/10.4244/EIJ-D-22-00619
5. Fetterly, K. A., Schueler, B. A., Mihailovic, J. M., Fiedler, J. H., Sturchio, G. M., Cabalka, A., & Miller, D. L. (2024). Radiation exposure and protection for (assumed) pregnant interventional cardiologists and electrophysiologists. Journal of the Society for Cardiovascular Angiography & Interventions, 3(9), 102239. https://doi.org/10.1016/j.jscai.2024.102239
6. Chen, S. H., & Brunet, M. C. (2020). Fetal radiation exposure risk in the pregnant neurointerventionalist. Journal of Neurointerventional Surgery, 12(10), 1014–1017. https://doi.org/10.1136/neurintsurg-2019-015549
7. Biegała, M., Jakubowska, T., & Domienik-Andrzejewska, J. (2024). Exposure to ionizing radiation of medical staff performing vascular and interventional radiology procedures. International Journal of Occupational Medicine and Environmental Health, 37, 403–410. https://doi.org/10.13075/ijomeh.1896.02214
8. Archives of Medical Science. (2025). Exposure of pregnant women to ionizing radiation during interventional radiology and computed tomography procedures. Archives of Medical Science, 21(3), 597–605. https://doi.org/10.5114/aoms/208440
9. United Nations Scientific Committee on the Effects of Atomic Radiation. (2021). Sources, effects and risks of ionizing radiation: UNSCEAR 2020/2021 report, volume I. United Nations. https://www.unscear.org
10. International Commission on Radiological Protection. (2019). Dose limits. ICRPædia. https://icrpaedia.org/Dose_limits
11. Nuclear Regulatory Commission. (n.d.). Standards for protection against radiation (10 CFR 20). https://www.nrc.gov/reading-rm/doc-collections/cfr/part020/
12. Occupational Safety and Health Administration. (n.d.). Ionizing radiation—pregnant workers. https://www.osha.gov/ionizing-radiation/pregnant-workers
13. Tufts University. (n.d.). Pregnancy and radiation safety. https://viceprovost.tufts.edu/policies-forms-guides/pregnancy-and-radiation-safety
14. RadCare Services. (2025). Radiation protection during pregnancy: A practical guide. https://radcareservices.com/blog/a-guide-to-radiation-protection-during-pregnancy-protecting-patients-and-healthcare-workers/
15. Meek, M., Chang, M., Lensing, S., & Deloney, L. (2016). Radiation exposure in pregnant and nonpregnant female interventional radiology workers. Radiologic Technology, 87(5), 574–578. https://pubmed.ncbi.nlm.nih.gov/27133935/
16. Wunderle, K. A., Chung, M. K., Rayadurgam, S., Miller, M. A., Obuchowski, N. A., & Lindsay, B. D. (2019). Occupational and patient radiation doses in a modern cardiac electrophysiology laboratory. Journal of Interventional Cardiac Electrophysiology, 56(2), 183–190. https://doi.org/10.1007/s10840-019-00542-3
17. Applied Radiology. (2024). Quality and safety in medical imaging during pregnancy and lactation—Part I. https://appliedradiology.com/Articles/quality-and-safety-in-medical-imaging-during-pregnancy-and-lactation-part-i
18. American College of Obstetricians and Gynecologists. (2017). Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. https://www.acog.org
19. European Society of Radiology. (2020). ESR statement on the use of diagnostic imaging in pregnant patients. https://www.myesr.org
20. Modarai, B., Haulon, S., Ainsbury, E., Bockler, D., Vano-Carruana, E., Dawson, J., & European Society for Vascular Surgery. (2023). ESVS 2023 clinical practice guidelines on radiation safety. European Journal of Vascular and Endovascular Surgery, 65(2), 171–222. https://doi.org/10.1016/j.ejvs.2022.10.017
21. Miller, D. L., Balter, S., Schueler, B. A., Wagner, L. K., Strauss, K. J., & Vano, E. (2010). Clinical radiation management for fluoroscopically guided interventional procedures. Radiology, 257(2), 321–332. https://doi.org/10.1148/radiol.10100063
22. Domienik-Andrzejewska, J., Kałużny, P., Piernik, G., & Jurewicz, J. (2019). Occupational exposure to ionizing radiation and lens opacity in interventional cardiologists. International Journal of Occupational Medicine and Environmental Health, 32, 663–675. https://doi.org/10.13075/ijomeh.1896.01700
23. Mirowski, M., Domienik-Andrzejewska, J., & Moszura, T. (2024). Patient and physician exposure to X-rays at pediatric interventional cardiology—from world to Poland. International Journal of Occupational Medicine and Environmental Health, 37, 569–580. https://doi.org/10.13075/ijomeh.1896.02254
24. Sebastià, N., Olivares-González, L., Montoro, A., Barquinero, J. F., Canyada-Martinez, A. J., Hervás, D., & Rodrigo, C. (2020). Redox status, dose and antioxidant intake in healthcare workers occupationally exposed to ionizing radiation. Antioxidants, 9(9), 778. https://doi.org/10.3390/antiox9090778
25. Xhuti, D., Rebalka, I. A., Minhas, M., May, L., Murphy, K., Nederveen, J. P., & Wells, G. D. (2023). The acute effect of multi-ingredient antioxidant supplementation following ionizing radiation. Nutrients, 15(1), 207. https://doi.org/10.3390/nu15010207
26. Sun, L., Igarashi, T., Tetsuka, R., Li, Y. S., Kawasaki, Y., Kawai, K., & Yoshida, K. (2019). Pilot clinical study of ascorbic acid treatment in cardiac catheterization. Journal of Radiation Research, 60(5), 573–578. https://doi.org/10.1093/jrr/rrz045
27. Velauthapillai, N., Barfett, J., Jaffer, H., Mikulis, D., & Murphy, K. (2017). Antioxidants taken orally prior to diagnostic radiation exposure can prevent DNA injury. Journal of Vascular and Interventional Radiology, 28(3), 406–411. https://doi.org/10.1016/j.jvir.2016.11.036